Kuwabara, M.; Hisatome, I.; Niwa, K.; Bjornstad, P.; Roncal-Jimenez, C.A.; Andres-Hernando, A.; Kanbay, M.; Johnson, R.J.; Lanaspa, M.A.
The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study. J. Clin. Med. 2020, 9, 942.
https://doi.org/10.3390/jcm9040942
AMA Style
Kuwabara M, Hisatome I, Niwa K, Bjornstad P, Roncal-Jimenez CA, Andres-Hernando A, Kanbay M, Johnson RJ, Lanaspa MA.
The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study. Journal of Clinical Medicine. 2020; 9(4):942.
https://doi.org/10.3390/jcm9040942
Chicago/Turabian Style
Kuwabara, Masanari, Ichiro Hisatome, Koichiro Niwa, Petter Bjornstad, Carlos A. Roncal-Jimenez, Ana Andres-Hernando, Mehmet Kanbay, Richard J. Johnson, and Miguel A. Lanaspa.
2020. "The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study" Journal of Clinical Medicine 9, no. 4: 942.
https://doi.org/10.3390/jcm9040942
APA Style
Kuwabara, M., Hisatome, I., Niwa, K., Bjornstad, P., Roncal-Jimenez, C. A., Andres-Hernando, A., Kanbay, M., Johnson, R. J., & Lanaspa, M. A.
(2020). The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study. Journal of Clinical Medicine, 9(4), 942.
https://doi.org/10.3390/jcm9040942